Scientists at the University of British Columbia and BetaLogics have reversed diabetes in mice using stem cells.
Isabella Kruger, 3-Year-Old Cloned Skin Recipient, To Leave Hospital – Huffington Post
Isabella Kruger, 3-Year-Old Cloned Skin Recipient, To Leave HospitalHuffington PostJOHANNESBURG — Bedtime for 3-year-old Isabella Kruger now includes a bottle and a massage. This ritual has become possible again as the toddler recovers from surgery th…
New dialysis center opens in Waukegan
WAUKEGAN — Fresenius Medical Care’s Waukegan Harbor dialysis center has opened just west of the city’s downtown at 110 N. West St. Officials with Fresenius Medical Care North America, headquartered in Waltham, Mass., said the 21-station clinic wi…
New drug dramatically improves survival in Hodgkin lymphoma patients
( Loyola University Health System ) A new cancer drug with remarkably few side effects is dramatically improving survival in Hodgkin lymphoma patients who fail other treatments and are nearly out of options.
Expert: New treatments for hepatitis C patients
EXETER — A nationally recognized hepatitis C expert from Massachusetts General Hospital told patients infected in the Exeter Hospital hepatitis C outbreak that they may have the option of receiving some cutting edge medication that could treat the in…
Monkey gets pig heart
London, June 27 (IANS) The heart of a genetically modified pig has been successfully transplanted into a monkey by scientists in South Korea, it was reported here.
Benefit planned to help heart transplant recipient
Friends and neighbors are coming together to lend a helping hand to Daniel Slack, 30, who had a heart transplant at Mayo Clinic in Rochester, Minn., April 14.
Toddler recovering after receiving skin transplant from cloned mouse cells – MyFox Washington DC
Toddler recovering after receiving skin transplant from cloned mouse cellsMyFox Washington DCA South African toddler is recovering after receiving a transplant of cloned skin to treat severe burns. Three-year-old Isabella Kruger suffered burns to over …
Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous …
MONMOUTH JUNCTION, N.J., June 27, 2012 /PRNewswire/ — Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced that the first patient has been dosed in the Company's U.S. phase …
Centralised organ donation register reaches 100000 mark – 7thSpace Interactive (press release)
PSFKCentralised organ donation register reaches 100000 mark7thSpace Interactive (press release)Centralised organ donation register reaches 100000 mark – up-to-the-minute … It is easy to register as an organ donor. … Registration forms are also avai…